AAAAAA

   
Results: 1-7 |
Results: 7

Authors: Gudmundsson, OS
Citation: Os. Gudmundsson, Additional transporter characterization may lead to new pharmaceutical opportunities, PHARM RES, 18(11), 2001, pp. 1481-1482

Authors: Gudmundsson, OS Jois, SDS Vander Velde, DG Siahaan, TJ Wang, B Borchardt, RT
Citation: Os. Gudmundsson et al., The effect of conformation on the membrane permeation of coumarinic acid- and phenylpropionic acid-based cyclic prodrugs of opioid peptides, J PEPT RES, 53(4), 1999, pp. 383-392

Authors: Bak, A Siahaan, TJ Gudmundsson, OS Gangwar, S Friis, GJ Borchardt, RT
Citation: A. Bak et al., Synthesis and evaluation of the physicochemical properties of esterase-sensitive cyclic prodrugs of opioid peptides using an (acyloxy)alkoxy linker, J PEPT RES, 53(4), 1999, pp. 393-402

Authors: Gudmundsson, OS Vander Velde, DG Jois, SDS Bak, A Siahaan, TJ Borchardt, RT
Citation: Os. Gudmundsson et al., The effect of conformation of the acyloxyalkoxy-based cyclic prodrugs of opioid peptides on their membrane permeability, J PEPT RES, 53(4), 1999, pp. 403-413

Authors: Gudmundsson, OS Pauletti, GM Wang, W Shan, DX Zhang, HJ Wang, BH Borchardt, RT
Citation: Os. Gudmundsson et al., Coumarinic acid-based cyclic prodrugs of opioid peptides that exhibit metabolic stability to peptidases and excellent cellular permeability, PHARM RES, 16(1), 1999, pp. 7-15

Authors: Gudmundsson, OS Nimkar, K Gangwar, S Siahaan, T Borchardt, RT
Citation: Os. Gudmundsson et al., Phenylpropionic acid-based cyclic prodrugs of opioid peptides that exhibitmetabolic stability to peptidases and excellent cellular permeation, PHARM RES, 16(1), 1999, pp. 16-23

Authors: Bak, A Gudmundsson, OS Friis, GJ Siahaan, TJ Borchardt, RT
Citation: A. Bak et al., Acyloxyalkoxy-based cyclic prodrugs of opioid peptides: Evaluation of the chemical and enzymatic stability as well as their transport properties across Caco-2 cell monolayers, PHARM RES, 16(1), 1999, pp. 24-29
Risultati: 1-7 |